Given that ACSL4 is the key execution factor of ferroptosis, further studies are warranted to clarify the factors that elevate ACSL4 at the transcriptional or posttranscriptional level, possibly involving some transcriptional activators or deubiquitinases, which may uncover natural suppressors of tumor development and drug resistance. Here, ACSL4 is linked to neoplasm.